STOCK TITAN

CRH Public Limited Company Form 4 Filings

CRH NYSE

Every Form 4 that CRH Public Limited Company (CRH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CRH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRH filings page.

Rhea-AI Summary

CRH PUBLIC LTD CO officer Padraig ORiordain reported an open-market sale of 1,492 Ordinary Shares. The shares were sold on May 15, 2026 at an average price of $104.445 per share. After this transaction, he directly owns 1,205 Ordinary Shares. The footnote notes that the reported price reflects the sale price and that detailed trade breakdowns are available to the SEC on request.

Rhea-AI Summary

CRH PUBLIC LTD CO director Badar Khan reported routine equity compensation activity. On May 13, 2026, 1,976 restricted share units vested and were exercised into 2,004 Ordinary Shares, including 28 additional shares as dividend equivalents under the company’s equity incentive plan.

To cover related tax liabilities, 962 Ordinary Shares were mandatorily withheld, leaving Khan with 3,542 Ordinary Shares directly held after these transactions. Separately, he received a new time-based conditional award of 1,556 restricted share units, each representing one future Ordinary Share, scheduled to vest in May 2027 with dividend equivalents applying on vesting.

Rhea-AI Summary

CRH PUBLIC LTD CO director Christina Campbell Verchere reported compensation-related equity transactions involving Ordinary Shares and Restricted Share Units on May 13, 2026. She exercised derivative awards for 2,004 Ordinary Shares at $0.00 per share and received a new grant of 1,556 Restricted Share Units, each representing one Ordinary Share.

A total of 962 Ordinary Shares were disposed of at $108.75 per share to satisfy tax withholding obligations arising from the vesting of a prior time-based RSU award under the CRH plc 2025 Equity Incentive Plan, rather than through an open-market sale. Following these transactions, she directly held 2,042 Ordinary Shares in one line item and 1,556 RSUs in another.

Rhea-AI Summary

CRH Public Ltd Co officer Padraig O’Riordain reported compensation-related share movements. On May 13, 2026, one-third of a time-based award of 7,464 restricted share units vested, resulting in 2,488 Ordinary Shares being delivered under the equity incentive plan.

To cover withholding tax liabilities from this vesting, 1,317 Ordinary Shares were mandatorily sold at a volume-weighted average price of $110.4137, with sale prices ranging from $109.02 to $111.515. Following these transactions, O’Riordain directly holds 2,697 Ordinary Shares and 10,612 restricted share units.

Rhea-AI Summary

CRH PUBLIC LTD CO director Caroline Dowling reported equity compensation-related transactions involving Ordinary Shares and Restricted Share Units (RSUs). On May 13, 2026, 1,976 RSUs vested and were exercised into Ordinary Shares under the CRH plc 2025 Equity Incentive Plan, reflecting a time-based award with dividend equivalents. To cover associated tax liabilities, 1,047 Ordinary Shares were automatically withheld, a non-market disposition. On the same date, she also received a new grant of 1,556 RSUs, which is scheduled to vest in May 2027. Following these transactions, she directly holds 3,004 Ordinary Shares and 1,556 RSUs, indicating a net increase in her overall equity exposure to CRH driven by routine compensation events rather than open-market trading.

Rhea-AI Summary

CRH PUBLIC LTD CO director Johan Karlstrom reported compensation-related share activity. On May 13, 2026, 1,976 Restricted Share Units vested and were exercised into 2,004 Ordinary Shares, including 28 shares from dividend equivalents, under the CRH plc 2025 Equity Incentive Plan. To cover related tax liabilities, 962 Ordinary Shares were mandatorily withheld, a non‑market disposition. Karlstrom also received a new time-based award of 1,556 RSUs, each convertible into one Ordinary Share, scheduled to vest in May 2027. Following these transactions, he directly owns 3,042 Ordinary Shares.

Rhea-AI Summary

CRH Public Ltd Co director Richard Aidan Hugh Boucher reported RSU vesting, a new RSU grant, and related Ordinary Share movements on May 13, 2026. Restricted share units were exercised into Ordinary Shares and shares were withheld to cover tax liabilities. After these transactions he holds 2,594 restricted share units and 25,036 Ordinary Shares directly. Footnotes describe time-based RSU awards under the CRH plc 2025 Equity Incentive Plan, including dividend equivalents and mandatory share withholding for taxes.

Rhea-AI Summary

CRH PUBLIC LTD CO Chief Financial Officer Bryan Aylwyn reported routine equity compensation activity. On May 13, 2026, 1,169 Ordinary Shares were acquired through the vesting or exercise of awards, while 632 Ordinary Shares were disposed of to cover withholding tax liabilities at a volume-weighted average price of $110.4137 per share, with sale prices ranging from $109.02 to $111.515.

He also received a new grant of 5,407 Restricted Share Units under the company’s Equity Incentive Plan, each representing one Ordinary Share. Following these transactions, he directly holds 17,455 Ordinary Shares and 5,525 unvested Restricted Share Units, reflecting ongoing compensation rather than discretionary open-market trading.

Rhea-AI Summary

CRH Public Ltd Co Chief Strategy Officer Juan Pablo San Agustin reported the vesting of 2,708 restricted share units plus 37 dividend-equivalent shares, delivering 2,745 Ordinary Shares on May 13, 2026 under the Equity Incentive Plan. A mandatory sale of 1,247 shares at a volume-weighted average price of $110.4333 covered withholding taxes. Following these transactions, he directly owns 50,597 Ordinary Shares.

Rhea-AI Summary

CRH PUBLIC LTD CO Chief Executive Officer Denis James Mintern reported equity compensation-related transactions involving Ordinary Shares and restricted share units. He exercised awards covering 14,985 Restricted Share Units, which vested as one-third of a 44,955 RSU time-based award under the CRH plc 2025 Equity Incentive Plan, including dividend equivalents. To cover related withholding tax liabilities, there was a mandatory sale of 7,932 Ordinary Shares at a volume-weighted average price of $109.286, with individual sale prices ranging from $109.01 to $110.67. Following these transactions, Mintern directly holds 49,889 Ordinary Shares, indicating the activity is primarily routine vesting and tax withholding rather than an open-market trade.

Rhea-AI Summary

CRH Public Ltd Co Chief Human Resources Officer Kristin Lane reported routine equity compensation activity involving Ordinary Shares and Restricted Share Units. On May 13, 2026, 2,195 Restricted Share Units converted into the same number of Ordinary Shares, reflecting the vesting of part of a prior time-based award under the CRH plc 2025 Equity Incentive Plan. To cover related tax liabilities, 876 Ordinary Shares were withheld, a non-market disposition. Following these transactions, Lane held 18,361 Ordinary Shares directly and 374 Ordinary Shares indirectly through a 401(k) plan, while 10,184 Restricted Share Units remained outstanding for future vesting.

Rhea-AI Summary

Peck Thomas R Jr reported acquisition or exercise transactions in this Form 4 filing.

CRH PUBLIC LTD CO executive Thomas R. Peck Jr. received two compensation awards of Restricted Share Units (RSUs). One grant covers 17,988 RSUs, vesting half in December 2026 and a quarter in each of December 2027 and December 2028. A second award of 21,622 RSUs vests in equal thirds in May 2027, May 2028 and May 2029. Each RSU represents one Ordinary Share, carries dividend equivalents, and was granted at no cash cost.

Rhea-AI Summary

CRH PUBLIC LTD CO director Lamar McKay reported routine equity compensation activity. On May 13, 2026, 1,976 Restricted Share Units (RSUs) vested and converted into Ordinary Shares, together with 28 additional Ordinary Shares as dividend equivalents, for a total of 2,004 Ordinary Shares acquired.

To cover related tax liabilities, 962 Ordinary Shares were automatically withheld and disposed of at $108.75 per share, leaving McKay with 5,042 Ordinary Shares held directly. He also received a new time-based award of 1,556 RSUs, each representing one Ordinary Share, scheduled to vest in May 2027. The filing shows no open-market purchases or sales, only compensation-related grants, vesting and tax withholding.

Rhea-AI Summary

CRH public limited company director Mary K. Rhinehart reported compensation-related equity activity. She exercised 1,976 Restricted Share Units into Ordinary Shares, with 962 Ordinary Shares withheld at $108.75 each to cover tax liabilities, resulting in 3,300 Ordinary Shares held directly. She also received a new time-based award of 1,556 Restricted Share Units under the 2025 Equity Incentive Plan, which is scheduled to vest in May 2027 with dividend equivalents applied at vesting.

Rhea-AI Summary

CRH Chief Operating Officer Randy Lake reported equity compensation-related transactions on May 13, 2026. 6,294 restricted share units vested into the same number of Ordinary Shares under the 2025 Equity Incentive Plan, and 2,843 shares were withheld to cover related tax liabilities. Following these transactions, he directly holds 104,136 Ordinary Shares and 26,844 restricted share units.

Rhea-AI Summary

CRH Public Ltd Co’s President, Americas Division, Nathan Creech reported the vesting and conversion of 5,123 restricted share units into Ordinary Shares on May 13, 2026, under the CRH plc 2025 Equity Incentive Plan. He acquired 5,194 Ordinary Shares in total from this RSU release.

To cover related tax liabilities, 2,044 Ordinary Shares were withheld at $108.75 per share. Following these transactions, he directly holds 147,946 Ordinary Shares, with 54,783 restricted share units remaining outstanding.

Rhea-AI Summary

CRH PUBLIC LTD CO director Gillian L. Platt reported equity compensation activity involving restricted share units and related share movements. On May 13, 2026, 1,976 Restricted Share Units converted into 1,976 Ordinary Shares, and 962 Ordinary Shares were withheld to cover tax liabilities tied to the vesting.

Following these transactions, she held 2,199 Ordinary Shares directly. On the same date, she also received a new time-based conditional award of 1,556 Restricted Share Units under the CRH plc 2025 Equity Incentive Plan, which is scheduled to vest in May 2027 and will earn dividend equivalents until vesting.

Rhea-AI Summary

CRH Public Ltd Co director Siobhan Talbot reported several equity compensation-related transactions. On May 13, 2026, time-based restricted share units vested and were converted into 1,976 Ordinary Shares, with 1,047 Ordinary Shares withheld to cover tax liabilities, a non-market disposition.

Talbot also received a new time-based award of 1,556 Restricted Share Units under the CRH plc 2025 Equity Incentive Plan, each RSU representing one Ordinary Share and scheduled to vest in May 2027. Following these transactions, Talbot holds 8,507 Ordinary Shares directly.

Rhea-AI Summary

CRH executive Peter J. Buckley reported equity compensation activity on 2026-05-13. He exercised 3,439 Restricted Share Units, receiving 3,487 Ordinary Shares, and 1,742 shares were disposed of to satisfy tax withholding at a volume-weighted average price of $110.4333. After these transactions he directly holds 169,673 Ordinary Shares.

Rhea-AI Summary

CRH PUBLIC LTD CO director Richard H. Fearon reported routine equity compensation activity. On May 13, 2026, 1,976 restricted share units vested and were converted into Ordinary Shares, while 962 Ordinary Shares were withheld at $108.75 per share to cover related tax liabilities. Following these transactions, Fearon directly holds 145,804 Ordinary Shares. He also received a new grant of 1,556 restricted share units under the CRH plc 2025 Equity Incentive Plan, which is scheduled to vest in May 2027 and will accrue dividend equivalents until vesting.

Rhea-AI Summary

CRH PUBLIC LTD CO director Shaun Kelly reported equity compensation activity. On May 13, 2026, he exercised 1,976 Restricted Share Units into Ordinary Shares and had 962 Ordinary Shares withheld at $108.75 per share to cover tax liabilities related to this vesting.

Following these transactions, he directly held 5,042 Ordinary Shares. Kelly also received a new time-based conditional award of 1,556 Restricted Share Units under the CRH plc 2025 Equity Incentive Plan, each representing one Ordinary Share, scheduled to fully vest in May 2027.

Rhea-AI Summary

CRH Public Ltd Co Chief Development Officer Philip Wheatley exercised 1,976 restricted share units into Ordinary Shares on May 13, 2026, receiving 2,003 shares from a time-based award granted in May 2025. To cover withholding taxes, 1,046 shares were sold at a volume-weighted average price of $110.4137. After these transactions, he directly holds 51,999 Ordinary Shares, with the remaining portions of the 5,928 RSU award scheduled to vest in May 2027 and May 2028.

Rhea-AI Summary

CRH Public Ltd Co director Richard H. Fearon bought 3,800 Ordinary Shares in an open-market transaction at $104.49 per share. This purchase increased his direct holdings to 143,800 Ordinary Shares, showing he added modestly to his existing position.

Rhea-AI Summary

CRH Public Ltd Co director Siobhan Talbot reported an open-market purchase of 2,000 Ordinary Shares of CRH on March 12, 2026 at an average price of $102.1117 per share. After this transaction, she directly holds 7,550 Ordinary Shares in the company.

Rhea-AI Summary

CRH plc reported that Nathan Creech, President of the Americas Division, received multiple equity awards and vesting-related share deliveries on February 23, 2026. He acquired 9,188 deferred shares upon exercise of derivative awards and was granted 11,603 restricted share units, each representing one ordinary share, under the CRH plc Equity Incentive Plan with one-third scheduled to vest in February 2027, 2028 and 2029. He also received ordinary shares through the vesting of prior performance- and time-based awards, while 29,134 ordinary shares were withheld at a price of $121.49 per share to satisfy tax liabilities arising from these awards.

Rhea-AI Summary

CRH plc Chief Strategy Officer Juan Pablo San Agustin reported multiple equity award transactions. On February 24, 2026, he acquired 4,119 Deferred Share Awards through an exercise of derivative securities and received a grant of 27,293 Ordinary Shares, tied to performance-based awards granted in 2023.

He also acquired 4,422 Ordinary Shares from the vesting of a time-based deferred share award. To cover related withholding tax liabilities, there was a mandatory sale of 15,344 Ordinary Shares at a volume‑weighted average price of $121.8059, with sale prices ranging from $120.15 to $122.82. On February 23, 2026, he was granted 6,920 Restricted Share Units, each representing one Ordinary Share and vesting in three equal annual installments beginning in February 2027.

Rhea-AI Summary

CRH PUBLIC LTD CO officer Peter J. Buckley reported several equity compensation transactions. On February 24, 2026, he acquired 24,186 Ordinary Shares at a stated price of $0.00 per share through the vesting and release of performance-based awards granted in 2023, including 1,652 dividend-equivalent shares. On the same date, 11,864 Ordinary Shares were disposed of in a mandatory sale to cover withholding tax liabilities, at a volume-weighted average price of $121.8059 per share, with individual sale prices ranging from $120.15 to $122.82. After these transactions, he directly held 167,928 Ordinary Shares. On February 23, 2026, he also received a grant of 9,173 Restricted Share Units under the CRH plc Equity Incentive Plan, each RSU representing one Ordinary Share, with one-third scheduled to vest on the grant anniversary in February 2027, 2028 and 2029, with dividend equivalents to be reported at vesting.

Rhea-AI Summary

CRH PUBLIC LTD CO Chief Human Resources Officer Kristin Lane reported equity compensation activity tied to prior awards and a new grant. On February 23, 2026, Lane acquired 15,262 Ordinary Shares at no cost upon vesting of 2023 performance share awards, including 1,042 additional shares credited as dividend equivalents, following certification of performance by the Compensation Committee.

She also received a time-based grant of 5,794 Restricted Share Units, each representing one future Ordinary Share, with one-third scheduled to vest in February 2027, 2028 and 2029 under the CRH plc Equity Incentive Plan. To cover tax liabilities from the vesting, 6,006 Ordinary Shares were disposed of through mandatory share withholding at $121.49 per share. After these transactions, Lane directly owned 17,012 Ordinary Shares and 12,379 RSUs, and indirectly held 374 Ordinary Shares through a 401(k) plan.

Rhea-AI Summary

Buese Nancy reported acquisition or exercise transactions in this Form 4 filing.

CRH Public Limited Company Chief Financial Officer Nancy Buese received a grant of 13,261 restricted share units. Each unit represents the right to receive one ordinary share of CRH under the company’s equity incentive plan.

The award is time-based, with one-third of the RSUs scheduled to vest on the grant anniversary in February 2027, 2028, and 2029. Following this grant, Buese directly holds 52,782 restricted share units. Dividend equivalents will apply to these awards and will be delivered when the units vest.

Rhea-AI Summary

CRH plc Chief Operating Officer Randy Lake reported multiple equity-related transactions on February 23, 2026. He acquired 15,897 Deferred Shares through the exercise or conversion of derivative awards and received 14,256 Restricted Share Units as a time-based conditional award under the company’s Equity Incentive Plan.

Lake was also granted 73,767 Ordinary Shares and acquired a further 17,064 Ordinary Shares upon vesting of a time-based conditional award under the Deferred Share Bonus Plan, with both performance-based and time-based awards including additional shares as dividend equivalents. To cover tax liabilities from these vestings, 40,457 Ordinary Shares were disposed of at $121.49 per share through mandatory share withholding.

Rhea-AI Summary

CRH Chief Executive Officer Denis James Mintern reported several equity compensation moves. A time-based award vested, delivering 14,372 Ordinary Shares, and 7,502 of those shares were mandatorily sold to cover withholding taxes at a volume-weighted average price of $120.7838, with sale prices between $120.011 and $122.17. He also exercised derivative awards into 13,389 Deferred Shares and received a grant of 41,281 Restricted Share Units, which will vest in three equal installments on the grant anniversaries in February 2027, 2028 and 2029. Following these transactions, he directly holds 42,627 Ordinary Shares, 16,271 Deferred Shares and 86,236 Restricted Share Units.

Rhea-AI Summary

ORiordain Padraig reported acquisition or exercise transactions in this Form 4 filing.

CRH PUBLIC LTD CO reported that officer Padraig O'Riordain received a grant of 5,636 Restricted Share Units on Ordinary Shares. These units are a time-based conditional award under the CRH plc Equity Incentive Plan. One-third of the award will vest on each grant anniversary in February 2027, 2028 and 2029. Following this grant, O'Riordain holds 13,100 Restricted Share Units directly. Dividend equivalents will apply to these awards and will be reported when the units vest.

Rhea-AI Summary

CRH plc Chief Development Officer Philip Wheatley reported equity compensation activity on February 23, 2026. He received 4,476 restricted share units, each representing one ordinary share, as a time-based award under the company’s equity incentive plan.

On the same date, 28,466 ordinary shares were delivered following vesting of performance-based awards originally granted in 2023, including dividend equivalents. A further 14,860 ordinary shares were sold at a volume-weighted average price of $121.1719 to cover withholding tax obligations related to this award.